DEVELOPMENT & MANUFACTURE OF ORAL DOSAGE FORMS

本合同的目的是开发和生产口腔 将用于人体临床试验的药物剂型 在国家癌症研究所的赞助下。 这些药会 通常由抗癌和抗艾滋病化合物组成。 剂型将 包括但不限于片剂、肠溶包衣片剂、胶囊剂 软明胶胶囊、胶囊化颗粒和口服粉末， 解决方案承包商应根据试验和 强度、同一性和性能特征的生产运行。 设施、设备和程序应符合FDA规定 现行良好生产规范（CGMP）。

The objective of this Contract is the development and manufacture of oral dosage forms of drugs which will be used for human clinical trials carried out under the auspices of the National Cancer Institute. Those drugs will usually consist of anti-cancer and anti-AIDS compounds. Dosage forms will include but not be limited to tablets, enteric coated tablets, capsules, soft gelatin capsules, encapsulated granules and oral powders and solutions. The contractor shall test the products from experimental and manufacturing runs for strength, identity and performance characteristics. Facilities, equipment and procedures shall conform to FDA prescribed Current Good Manufacturing Practices (CGMP).